Recalls / Active ingredient / Tralokinumab
Tralokinumab
1 FDA drug recall involving the active ingredient “Tralokinumab”.
| Date | Class | Product | Firm |
|---|---|---|---|
| 2026-02-10 | Class II | Adbry, (tralokinumab-ldrm) injection, 300 mg/2mL, Packaged as a) 1 x Single dose Autoinjector, SAMPLE NOT FOR | LEO PHARMA INC |